Legal

China clamps down on small-cap U.S. listings by Chinese issuers; China mandates personal information protection compliance audits for companies; and AI company loses against Reuters in U.S. summary judgment with key implication

State Council defines concentrations of business operators of the pharmaceutical sector. Network trading platform operators are required to submit information on the identities of online trading business operators. SPC clarifies on the contract governing law in Hong Kong and Macao investments in the Greater Bay Area.

Philip Qu of TransAsia Lawyers analyze regulatory and statutory progress in China’s ever flourishing TMT sector in 2024, and look at the outlook for 2025

Trump signs memorandum to restrict investments that do not serve American interests; A Jiangsu court ruled that investments in overseas crypto projects are not protected under Chinese law; and Chinese companies raise funds in hope of easing of regulations against private enterprises

2024 marked another significant year in China’s intellectual property law space. Danlei Wu of Fangda Partners examines the key developments and the indicators for further developments in the year ahead

Regulatory ratings of insurance companies include corporate governance, solvency, liability quality and asset quality / CLP Reference: 3910/25.01.07 ; Issued: 2025-01-07 ; Effective: 2025-03-01

Data centers are required to safeguard the security of the customer’s own training datasets

CSRC clarifies on the shareholding changes in takeovers of listed companies. / CLP Reference: 3700/25.01.10 ; Issued: 2025-01-10 ; Effective: 2025-01-10

Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications